Biox Cell News Today

Windjammer Capital Investors has announced it has closed its latest fund at $1.3 billion in commitments. The new fund, Windjammer Capital Fund VI, exceeded its $1...

/PRNewswire/ -- Windjammer Capital Investors ("Windjammer"), a national private equity investment firm focused on control equity investments in middle-market...

Lebanon’s Science Olympiad success was a team effortAs the coach of the Lebanon High School Science Olympiad team, I would like to express my thanks and gratitude, on behalf of our students, to the stakeholders in our community who have been so...

Reporting a novel hybrid membrane nanovaccine, composed of mesoporous silica nanoparticle as a delivery carrier

NH Business Review NH companies attract investment and recognition ... and more May 27, 2021 MilliporeSigma’s launches new synthetic cholesterol product, which could be used in mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine. MilliporeSigma has launched a new product nine months ahead of schedule in order to meet what it says is the high demand for lipids, a key component of mRNA-based vaccines and therapeutics. The German manufacturer, which has a location in Jaffrey, NH, is ma...

Abstract Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. Here, we developed a bispecific antibody (bsAb; B7-H3×4-1BB), targeting human B7-H3 (hB7-H3) and mouse or human 4-1BB, to restrict the 4-1BB stimulation in tumors. B7-H3×m4-1BB elicited a 4-1BB–dependent antitumor response in hB7-H3–overexpressing tumor models without systemic toxicity. BsAb primarily targets CD8 T cells in the tumor and increases their proliferati...